Home/Filings/4/0001104659-22-120080
4//SEC Filing

Shemesh Shay 4

Accession 0001104659-22-120080

CIK 0001875558other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 8:30 AM ET

Size

6.2 KB

Accession

0001104659-22-120080

Insider Transaction Report

Form 4
Period: 2022-11-16
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
  • Purchase

    Common Stock

    2022-11-16$7.10/sh+150$1,0651,245,215 total
  • Purchase

    Common Stock

    2022-11-17$7.20/sh+150$1,0801,245,365 total
Footnotes (1)
  • [F1]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.

Issuer

Nuvectis Pharma, Inc.

CIK 0001875558

Entity typeother

Related Parties

1
  • filerCIK 0001896056

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 8:30 AM ET
Size
6.2 KB